• Media type: E-Article
  • Title: A Retrospective Controlled Cohort Study of the Impact of Glucocorticoid Treatment in SARS-CoV-2 Infection Mortality
  • Contributor: Fernández-Cruz, Ana; Ruiz-Antorán, Belén; Muñoz-Gómez, Ana; Sancho-López, Aránzazu; Mills-Sánchez, Patricia; Centeno-Soto, Gustavo Adolfo; Blanco-Alonso, Silvia; Javaloyes-Garachana, Laura; Galán-Gómez, Amy; Valencia-Alijo, Ángela; Gómez-Irusta, Javier; Payares-Herrera, Concepción; Morrás-Torre, Ignacio; Sánchez-Chica, Enrique; Delgado-Téllez-de-Cepeda, Laura; Callejas-Díaz, Alejandro; Ramos-Martínez, Antonio; Múñez-Rubio, Elena; Avendaño-Solá, Cristina
  • imprint: American Society for Microbiology, 2020
  • Published in: Antimicrobial Agents and Chemotherapy
  • Language: English
  • DOI: 10.1128/aac.01168-20
  • ISSN: 0066-4804; 1098-6596
  • Keywords: Infectious Diseases ; Pharmacology (medical) ; Pharmacology
  • Origination:
  • Footnote:
  • Description: <jats:p>Evidence to support the use of steroids in coronavirus disease 2019 (COVID-19) pneumonia is lacking. We aim to determine the impact of steroid use for COVID-19 pneumonia on hospital mortality. We performed a single-center retrospective cohort study in a university hospital in Madrid, Spain, during March of 2020. To determine the role of steroids in in-hospital mortality, patients admitted with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia and treated with steroids were compared to patients not treated with steroids, and we adjusted with a propensity score for patients on steroid treatment.</jats:p>
  • Access State: Open Access